{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:58:51Z","timestamp":1790344731796,"version":"4.1.0"},"reference-count":21,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"9","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2026,9,25]]},"DOI":"10.1167\/tvst.15.9.19","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:00:55Z","timestamp":1790341255000},"page":"19","source":"Crossref","is-referenced-by-count":0,"title":["Survival of Patients With\n                    <i>MBD4<\/i>\n                    -Mutated Metastatic Uveal Melanoma Treated With Immune Checkpoint Inhibitors"],"prefix":"10.1167","volume":"15","author":[{"given":"Natasha","family":"Honor\u00e9","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Institut Curie, Paris, France"},{"name":"Medical Oncology Department, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Institut Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Piperno-Neumann","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Institut Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Pierron","sequence":"additional","affiliation":[{"name":"Somatic Genetic Unit, Department of Genetics, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Le Ven","sequence":"additional","affiliation":[{"name":"DRUM Team, INSERM U1339\/UMR 3666, Institut Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Houy","sequence":"additional","affiliation":[{"name":"DRUM Team, INSERM U1339\/UMR 3666, Institut Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Servois","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vincent-Salomon","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institut Curie, PSL Research University, Institut Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Mariani","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Institut Curie, PSL Research University, Institut Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cassoux","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"Department of Ocular Oncology, Institut Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Matet","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"Department of Ocular Oncology, Institut Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toulsie","family":"Ramtohul","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrystelle","family":"Colas","sequence":"additional","affiliation":[{"name":"DRUM Team, INSERM U1339\/UMR 3666, Institut Curie, Paris, France"},{"name":"Constitutional Genetic Unit, Department of Genetics, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Institut Curie, Paris, France"},{"name":"DRUM Team, INSERM U1339\/UMR 3666, Institut Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"1","key":"bib1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"bib2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11912-025-01684-0","article-title":"State-of-the-art in metastatic uveal melanoma treatment: a 2025 update: how to treat metastatic uveal melanoma in 2025","volume":"27","author":"Ziogas","year":"2025","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"bib3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41571-022-00714-1","article-title":"Advances in the clinical management of uveal melanoma","volume":"20","author":"Carvajal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"bib4","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy\u2014current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"issue":"6","key":"bib5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1200\/JCO.20.00605","article-title":"Nivolumab and ipilimumab in metastatic uveal melanoma: results from a single-arm phase II study","volume":"39","author":"Pelster","year":"2021","journal-title":"J Clin Oncol"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejca.2022.06.033","article-title":"MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients","volume":"173","author":"Saint-Ghislain","year":"2022","journal-title":"Eur J Cancer"},{"issue":"1","key":"bib7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s10238-024-01497-8","article-title":"Immunotherapy response and resistance in patients with advanced uveal melanoma: a retrospective cohort study","volume":"24","author":"Maurer","year":"2024","journal-title":"Clin Exp Med"},{"issue":"1","key":"bib8","doi-asserted-by":"publisher","first-page":"e000331","DOI":"10.1136\/jitc-2019-000331","article-title":"Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study","volume":"8","author":"Najjar","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"1","key":"bib9","doi-asserted-by":"publisher","first-page":"7887","DOI":"10.1038\/s41598-024-55675-5","article-title":"Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis","volume":"14","author":"Yamada","year":"2024","journal-title":"Sci Rep"},{"issue":"24","key":"bib10","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1056\/NEJMoa2304753","article-title":"Three-year overall survival with tebentafusp in metastatic uveal melanoma","volume":"389","author":"Hassel","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"bib11","doi-asserted-by":"publisher","first-page":"2116845","DOI":"10.1080\/2162402X.2022.2116845","article-title":"Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients","volume":"11","author":"Sala\u00fcn","year":"2022","journal-title":"Oncoimmunology"},{"issue":"8","key":"bib12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jamaophthalmol.2025.1779","article-title":"Uveal melanoma and the Lynch syndrome tumor spectrum","volume":"143","author":"Le Ven","year":"2025","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"bib13","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/jnci\/djad248","article-title":"Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants","volume":"116","author":"Villy","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"bib14","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1182\/blood-2018-05-852566","article-title":"MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML","volume":"132","author":"Sanders","year":"2018","journal-title":"Blood"},{"issue":"3","key":"bib15","first-page":"1133","article-title":"A germline MBD4 mutation was identified in a patient with colorectal oligopolyposis and early-onset cancer: a case report","volume":"42","author":"Tanakaya","year":"2019","journal-title":"Oncol Rep"},{"issue":"1","key":"bib16","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1038\/s41467-018-04322-5","article-title":"Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors","volume":"9","author":"Rodrigues","year":"2018","journal-title":"Nat Commun"},{"issue":"18","key":"bib17","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1158\/1078-0432.CCR-19-1215","article-title":"Evolutionary routes in metastatic uveal melanomas depend on MBD4 alterations","volume":"25","author":"Rodrigues","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"1","key":"bib18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/jnci\/djaa047","article-title":"Germline MBD4 mutations and predisposition to uveal melanoma","volume":"113","author":"Derrien","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"16","key":"bib19","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N Engl J Med"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"115634","DOI":"10.1016\/j.ejca.2025.115634","article-title":"Real-life data on tebentafusp in metastatic uveal melanoma patients from four EURACAN Expert Centres","volume":"227","author":"van der Kooij","year":"2025","journal-title":"Eur J Cancer"},{"issue":"11","key":"bib21","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.bulcan.2025.05.011","article-title":"Management of metastatic uveal melanoma: French expert consensus guidelines","volume":"112","author":"Rodrigues","year":"2025","journal-title":"Bull Cancer"}],"container-title":["Translational Vision Science &amp; Technology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/tvst.arvojournals.org\/article.aspx?doi=10.1167\/tvst.15.9.19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:00:56Z","timestamp":1790341256000},"score":1,"resource":{"primary":{"URL":"http:\/\/tvst.arvojournals.org\/article.aspx?doi=10.1167\/tvst.15.9.19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.15.9.19","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,25]]}}}